Edwards Lifesciences Corporation is a global leader in patient-focused innovations for structural heart disease and critical care monitoring. Founded in 1958, the company has a long history of developing innovative technologies to treat cardiovascular diseases. Edwards is particularly known for its transcatheter heart valve therapies, which provide less invasive options for patients with heart valve diseases. The company's mission is to help patients live longer, healthier lives by providing innovative solutions that improve the quality of care.